Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discounts will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
WuXi Biologics will purchase a Bayer plant for finished biologic drugs in Leverkusen, Germany. In addition to being used by the Chinese pharmaceutical services firm, the plant will be a backup site for making Bayer’s Kovaltry, a recombinant antihemophilic factor. From its base in China, WuXi Biologics has expanded rapidly in recent years. It is building a $60 million biologics plant in Worcester, Massachusetts, and a $390 million facility in Dundalk, Ireland.
This article has been sent to the following recipient: